CHU Nice — Nice

Public research footprint of CHU Nice, compiled from the ClinicalTrials.gov public registry.

357

Registered studies

134

Active

Recruiting now

167

Completed

Stopped or withdrawn

Most-studied conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive · Ulcerative Colitis in Remission · Amyotrophic Lateral Sclerosis (ALS) · Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control

Recently updated registry entries

NCT05531565 — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… (Active Not Recruiting)
NCT05269004 — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients… (Active Not Recruiting)
NCT07345325 — Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Nice?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.